Adma Biologics ADMA
NASDAQ ADMA
$12.79 +0.06 (+0.47%)
At close: Nov 9, 2026 · 4:00 PM EST

Adma Biologics (ADMA) Short-term Investments (2014 - 2017)

Updated

Adma Biologics (ADMA) recorded Short-term Investments of $245,000 in Q1 2017, down 95.5% from the prior quarter.

Analysis

Adma Biologics (ADMA) Short-term Investments (2014 - 2017) Analysis & Trends

At the end of FY2016, Adma Biologics reported Short-term Investments of $5.39 million, down 15.4% from FY2015.

  • Across earlier years, Short-term Investments came in at $6.37 million in FY2015 (+36.9%) and $4.65 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Adma Biologics 2.87 Bn 2.39 Bn 99.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 245,000.00
Dec 31, 2016 5.39 Mn
Dec 31, 2015 6.37 Mn
Dec 31, 2014 4.65 Mn
API Access

Adma Biologics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=ADMA&period=max&api_key=YOUR_API_KEY